Key facts
- This page summarizes Deborah Birx's Form 4 filing for Innoviva, Inc. (INVA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 May 2023, 17:56.
Deborah Birx - 22 May 2023 Form 4 Insider Report for Innoviva, Inc. (INVA)
- Reporting relationship
- Director
- Issuer ticker
- INVA
- Reported as of
- 22 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 May 2023, 17:56:18 UTC
- Prior SEC filing
- 27 Apr 2022
- Next SEC filing
- 19 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Deborah Birx
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Deborah Birx filed Form 4 for Innoviva, Inc. (INVA) on 24 May 2023.
Change
- Previous filing in this sequence was filed on 27 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INVA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +16,495
- Change %
- +39%
- Price
- $0.000000
- Shares after
- 58,984
- Date
- 22 May 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INVA
transaction
Derivative
Non-statutory Stock Option
Award
- Transaction value
- $0
- Shares
- +10,000
- Change %
- +100%
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 22 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $13.64
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs") and options upon the conclusion of the Issuer's 2023 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.